Pharsight

MEDIMMUNE LTD PATENTS FACING OPPOSITIONS

Top patents of MEDIMMUNE LTD facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3218406B1 24 Mar, 2021 Binding Molecules Specific For Cd73 And Uses Thereof Nov, 2035 2
EP3157629B1 05 Oct, 2022 Methods Of Cancer Treatment With Antagonists Against Pd-1 And Pd-L1 In Combination With Radiation Therapy Jun, 2035 1
EP3329018B1 31 Mar, 2021 Methods For Treating Hepcidin-Mediated Disorders Jul, 2036 1
EP2624859B1 01 Mar, 2017 Factor Ii And Fibrinogen For Treatment Of Haemostatic Disorders Sep, 2031 1